KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 162 filers reported holding KRYSTAL BIOTECH INC in Q1 2023. The put-call ratio across all filers is 1.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,429 | +431.5% | 20,939 | +266.5% | 0.03% | +460.0% |
| Q1 2023 | $457 | -85.1% | 5,714 | -85.3% | 0.01% | -86.5% |
| Q4 2022 | $3,072 | -98.1% | 38,774 | +1557.0% | 0.04% | +1750.0% |
| Q3 2022 | $163,000 | -88.9% | 2,340 | -89.6% | 0.00% | -87.5% |
| Q2 2022 | $1,475,000 | -43.3% | 22,470 | -42.5% | 0.02% | -15.8% |
| Q1 2022 | $2,602,000 | -29.1% | 39,101 | -25.5% | 0.02% | -5.0% |
| Q4 2021 | $3,670,000 | +34.7% | 52,470 | +0.6% | 0.02% | +53.8% |
| Q3 2021 | $2,724,000 | +11.1% | 52,182 | +44.8% | 0.01% | +18.2% |
| Q2 2021 | $2,451,000 | -15.7% | 36,041 | -4.5% | 0.01% | -26.7% |
| Q1 2021 | $2,908,000 | +12.8% | 37,750 | -12.2% | 0.02% | +7.1% |
| Q4 2020 | $2,579,000 | +5.3% | 42,988 | -24.4% | 0.01% | -12.5% |
| Q3 2020 | $2,449,000 | +186.1% | 56,879 | +175.1% | 0.02% | +128.6% |
| Q2 2020 | $856,000 | – | 20,676 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 895,000 | $68,951,000 | 5.53% |
| S Squared Technology, LLC | 85,215 | $6,565,000 | 3.10% |
| First Light Asset Management, LLC | 491,511 | $37,866,000 | 2.51% |
| Soleus Capital Management, L.P. | 166,844 | $12,854,000 | 2.32% |
| Redmile Group, LLC | 2,060,132 | $158,713,000 | 2.24% |
| Nicholas Investment Partners, LP | 304,689 | $23,473,000 | 1.64% |
| HighMark Wealth Management LLC | 17,192 | $1,324,000 | 1.06% |
| DSAM Partners (London) Ltd | 70,274 | $5,414,000 | 1.00% |
| Artal Group S.A. | 500,000 | $38,520,000 | 0.68% |
| Hood River Capital Management LLC | 237,882 | $18,326,000 | 0.59% |